New study examines the oral pathogen Porphyromonas gingivalis ( Pg ) and suggests its influence may extend beyond dental ...

Mito-TEMPO（AbMole，M10919）的作用机制不仅限于简单的ROS清除，它还能调节多种线粒体相关信号通路和细胞生命活动。例如Mito-TEMPO在MCF-7细胞中，逆转了DHA诱导的ROS依赖性自噬激活，通过调节p-AMPKα/p-Ra ...

Pharmacokinetics/Pharmacodynamics: Drug exposure at 200 mg appears to be in the efficacious range, however further results are awaited. Pharmacodynamic data demonstrated rapid and sustained IL-2 ...

Tiziana Life Sciences has pointed to increased Big Pharma interest in the IL-6 pathway as justification for its ...

Tiziana Life Sciences considers the antibody, known as TZLS-501, to have potential to operate as a standalone business and intends to proceed with steps for a publicly-listed immunology-focused ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that it intends to develop its ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

The resolution has been widely misinterpreted as conferring implicit recognition of Palestinian statehood. In fact, it ...

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today ...

Soficitinib is a potent and selective TYK2 inhibitor that is being developed for the treatment of various T-cell related autoimmune disorders. The Current indications under development are ...

We enrolled and completed dosing in the Phase Ib trial in AD patients with data coming in December. We initiated our first of ...